Microsoft word - meetings abstract titles- mohsen

ABSTRACTS PRESENTED IN NATIONAL OR INTERNATIONAL MEETING AND WORKSHOPS
1- Mohsen I. Afouna,
Ibrahim S. Khattab and Indra K. Reddy. Demeclocycline Liposomal Formulations:
Preparation, Characterization and Assessment of their Intra-ocular Pressure Lowering Effects using rabbit model, The 9th International Pharmaceutical Sciences Meeting and Exposition, Dec. (2005). 2- Mohsen I. Afouna, [Bio]availability of Topical Formulations: From Ambiguous Definition to Lack of
Generaliz[able] Approaches for Assessments. The 9th International Pharmaceutical Sciences Meeting and 3- Training workshop in “Application of Software in the Design of Advanced Learning website (Web CT). Center of
Development of Higher Education, King Abdul Aziz University, Jeddah, KSA. (2005). 4- Training workshop in “Effective Teaching Skills”. Center of Development of Higher Education, King Abdul
5- Training workshop in “Planning and Preparation of Multiple Choice Questions (MCQ) Exams. Center of
Development of Higher Education, King Abdul Aziz University, Jeddah, KSA, (2005).
6- Mohsen I. Afouna, Ibrahim, E. A., Kassem, Fincher K. I. and Reddy K. I. Stability Characterization of Long-
Acting Angiotensin Converting Enzyme Inhibitor; Enalapril Maleate Physical Mixtures with Selected Excipients Using Differential Scanning Calorimetry. The SRDG, Annual Meeting, Little Rock, AR, USA, May, 2002. 7- Mohsen I. Afouna, Ibrahim, E. A., Kassem, A., Fincher K. I. and Reddy K. I. Influence of Tablet
Manufacturing Technique on the Physic-mechanical Characteristics, of Enalapril Maleate Tablets. The AAPS Annual Meeting, Toronto, Canada, Oct. 2002 8- Fincher T. K., Mohsen I. Afouna, and Reddy I. K. Effect of the physicochemical characteristics upon the
permeability of drug using chiral terpene enhancers. The AAPS Annual Meeting, Montreal, Canada, Oct. 2002 9- Mohsen I. Afouna, Influence of Various Azone Concentrations upon Skin Target Site Free Drug
Concentration (C*) of Bromovinyldeoxyuridine (BVDU) and Acyclovir (ACV) Formulations Using Hairless Mice: A Comparative Study. The AAPS Annual Meeting, Colorado, Denver, USA, Oct. 2001. 10- Mohsen I. Afouna, Ibrahim, E. A., Kassem, A and El-Shattawy, H Stability Characterization of Long-
Acting Angiotensin Converting Enzyme Inhibitor; Enalapril Maleate Physical Mixtures with Selected Excipients Using Differential Scanning Calorimetry. The AAPS Annual Meeting, Colorado, Denver, USA, Oct. 2001. 11- EPS/AAPS/FIP workshop on the Bioequivalence Classification Systems, by the Egyptian Pharmacist
12- Mohsen I. Afouna, The in vivo Antiviral Efficacy of Cidofovir (HPMPC) and Acyclovir (ACV) Topical
Formulations with or without Azone Against Cutaneous HSV-1 Infection in Hairless Mice Employing Different Treatment Protocols. 15th Annual Meeting of American Association of Pharmaceutical Scientists, Indianapolis,
Indiana, USA
, Oct. (2000).
13- Pharmex Consulting Group Workshop on Percutaneous Drug Absorption; Mechanisms-Methodology-
Formulations Delivery-Toxicity, by Dr. Ghanem, A-H, and, Research Prof. of Pharmaceutics at the Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lack City, Utah, USA, 14- Mohsen I. Afouna, Mehta, S. C., Ghanem, A-H., Higuchi, W. I., Kern, E. R., DeClercq, E., and El-Shattawy,
H. Assessment of Correlation between the Skin Target Site Free Drug Concentration (C*) and the In-Vivo Efficacy for Bromovinyldeoxyuridine (BVDU) and Acyclovir Formulations in the Treatment of Cutaneous HSV-1 Infections in Hairless Mice, the 11th International Conference on Antiviral Research (Oral Session), San Diego, California, USA, April (1998). 15- Mohsen I. Afouna, Mehta, S. C., Ghanem, A-H., Higuchi, W. I., Kern, E. R., DeClercq, E., and El-Shattawy,
H. Absence of Correlation between C* Predictions and the In-Vivo Topical Antiviral Efficacy in Hairless Mice for Bromovinyldeoxyuridine (BVDU) Formulations. Twelfth Annual Meeting of American Association of
Pharmaceutical Scientists, Boston, Massachusetts, USA
, Nov. (1997).
16- Mehta, S. C., Mohsen I. Afouna, Ghanem, A-H., Higuchi, W. I., and Kern, E. R. The relationship of basal
Cell Layer Drug Concentration (C*) to the Antiviral Efficacy: A Rigorous Evaluation of the C* Concept for Prediction of the Entire Range of Topical Efficacy of Acyclovir Formulations in the Treatment of Cutaneous HSV-1 Infections in Hairless Mice, The10th International Conference on Antiviral Research, Atlanta, Georgia, USA, April (1997). 17- Mehta, S. C., Mohsen I. Afouna, Ghanem, A-H., Higuchi, W. I., Kern, E. R., DeClercq, E., and El-Shattawy,
H. Absence of Correlation between C* Predictions and the In-Vivo Topical Antiviral Efficacy in Hairless Mice
for Bromovinyldeoxyuridine (BVDU) Formulations. The 11th Annual Meeting of American Association of
Pharmaceutical Scientists, Seattle, Washington State, USA
, October (1996).

Source: http://mafonah.kau.edu.sa/Files/0052830/Files/7783_Meetings%20Abstract%20Titles-%20mohsen.pdf

Microsoft word - muscle spasm.doc

Anyone with ME/CFS would probably agree that their muscles are not working properly. There is pain (this is the ‘myalgia’ part of ‘Myalgic Encephalomyelitis’) and there is also tiredness and weakness of the muscles. And for some people with ME/CFS there is unfortunately an additional symptom: muscle spasms and twitching. Your doctor may consider low doses of muscle relaxant medicatio

cchit.org

CCHIT Certified® Ambulatory EHR Test Step FAQs Question Why we are keeping the record for the Joe Gardner that was It does not matter which record you keep as long as the jurors just created when there was already data for Joe Smith. Our can see that your system can electronically merge the two files process is to delete one record and while deleting it asks you if and the end result is

Copyright © 2008-2018 All About Drugs